Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China
We provided an observational report on the effectiveness and safety of the short-term use of DOR/3TC/TDF in routine clinical practice.
Authors
- Liu An (ORCID: https://orcid.org/0009-0005-2433-5889)
- L. Liu
- Aixin Li (ORCID: https://orcid.org/0000-0002-3158-0170)
- Jiangzhu Ye (ORCID: https://orcid.org/0000-0002-4456-7960)
- Lili Dai (ORCID: https://orcid.org/0000-0003-4886-9138)
- Jingji Zhang (ORCID: https://orcid.org/0000-0003-4989-4597)
- Zaicun Li (ORCID: https://orcid.org/0009-0005-0773-3316)
- Yue Gao (ORCID: https://orcid.org/0000-0002-0582-395X)
- Hongwei Zhang (ORCID: https://orcid.org/0000-0002-9971-4518)
- Jianwei Li (ORCID: https://orcid.org/0000-0003-2999-6932)
- Lijun Sun (ORCID: https://orcid.org/0000-0001-6603-5861)
- Xi Wang (ORCID: https://orcid.org/0009-0009-5146-8408)
Institutions
- Capital Medical University (CN)
- National Center for AIDS/STD Control and Prevention,China CDC (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-05-29
- DOI
- https://doi.org/10.3389/fmed.2025.1575411
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40